Cargando…

Oral Microbiome and Alzheimer’s Disease

The accumulation of amyloid-beta plaques in the brain is a central pathological feature of Alzheimer’s disease. It is believed that amyloid responses may be a result of the host immune response to pathogens in both the central nervous system and peripheral systems. Oral microbial dysbiosis is a chro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Jason, Fan, Hongkuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609607/ https://www.ncbi.nlm.nih.gov/pubmed/37894208 http://dx.doi.org/10.3390/microorganisms11102550

Ejemplares similares

Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
por: Doher, Nicholas, et al.
Publicado: (2023)

Strain-level dissection of the contribution of the gut microbiome to human metabolic disease
por: Zhang, Chenhong, et al.
Publicado: (2016)

Guild-based analysis for understanding gut microbiome in human health and diseases
por: Wu, Guojun, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
por: Paraskevas, George P., et al.
Publicado: (2021)

Using Optogenetics to Model Cellular Effects of Alzheimer’s Disease
por: Tiwari, Prabhat, et al.
Publicado: (2023)

Protecting against Pneumococcal Disease: Critical Interactions between Probiotics and the Airway Microbiome
por: Licciardi, Paul V., et al.
Publicado: (2012)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

A New Bistable Switch Model of Alzheimer’s Disease Pathogenesis
por: Burlando, Bruno, et al.
Publicado: (2022)

Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
por: Wu, Tong, et al.
Publicado: (2022)

Parasite microbiome project: Grand challenges
por: Dheilly, Nolwenn M., et al.
Publicado: (2019)

Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021)

Plasma Phospho-Tau-181 as a Diagnostic Aid in Alzheimer’s Disease
por: Tsantzali, Ioanna, et al.
Publicado: (2022)

Should the Human Microbiome Be Considered When Developing Vaccines?
por: Ferreira, Rosana B. R., et al.
Publicado: (2010)

Microbiome assembly in thawing permafrost and its feedbacks to climate
por: Ernakovich, Jessica G., et al.
Publicado: (2022)

Calmodulin and Amyloid Beta as Coregulators of Critical Events during the Onset and Progression of Alzheimer’s Disease
por: O’Day, Danton H.
Publicado: (2023)

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
por: Lazarczyk, Maciej J, et al.
Publicado: (2012)

Gut Microbes Meet Machine Learning: The Next Step towards Advancing Our Understanding of the Gut Microbiome in Health and Disease
por: Giuffrè, Mauro, et al.
Publicado: (2023)

Is a healthy microbiome responsible for lower mortality in COVID-19?
por: Janda, Lubomír, et al.
Publicado: (2020)

Mirror, mirror on the wall: which microbiomes will help heal them all?
por: Nayak, Renuka R., et al.
Publicado: (2016)

Human Microbiome in Children, at the Crossroad of Social Determinants of Health and Personalized Medicine
por: Sainz, Talía, et al.
Publicado: (2021)

Brain Mitochondrial Dysfunction: A Possible Mechanism Links Early Life Anxiety to Alzheimer’s Disease in Later Life
por: Wang, Qixue, et al.
Publicado: (2022)

Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids
por: Jia, Baolei, et al.
Publicado: (2019)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

Plant pathogen effector proteins as manipulators of host microbiomes?
por: Snelders, Nick C., et al.
Publicado: (2018)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Beta-amyloidolysis and glutathione in Alzheimer’s disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2013)

The microbiome in non-alcoholic fatty liver disease: associations and implications
por: Lin, Eugenia A., et al.
Publicado: (2014)

Vegetable microbiomes: is there a connection among opportunistic infections, human health and our ‘gut feeling'?
por: Berg, Gabriele, et al.
Publicado: (2014)

Is the gut microbiome of insects a potential source to meet UN sustainable development goals to eliminate plastic pollution?
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2023)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Alzheimer’s Disease – Why We Need Early Diagnosis
por: Rasmussen, Jill, et al.
Publicado: (2019)

Towards Astroglia-based Noradrenergic Hypothesis of Alzheimer’s Disease
por: Leanza, Giampiero, et al.
Publicado: (2022)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
por: Heng, Cai, et al.
Publicado: (2020)

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
por: Bouvy, Jacoline C., et al.
Publicado: (2018)

Retinopathy of prematurity and neonatal gut microbiome: An interview with Professor Dimitra Skondra, Associate Professor of Ophthalmology and Vitreoretinal Surgeon at The University of Chicago (USA)
por: Mammas, Ioannis N., et al.
Publicado: (2020)

Oral Candidiasis in Adult and Pediatric Patients with COVID-19
por: Pisano, Massimo, et al.
Publicado: (2023)

Oral healthcare workforce planning in post-Brexit Britain
por: Eaton, Kenneth A.
Publicado: (2020)

Type 2 diabetes as a disease of ectopic fat?
por: Sattar, Naveed, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aabnkak8oh4g2bncgaric5unis